{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:02:15Z","timestamp":1792270935357,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2369-12-53","type":"journal-article","created":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T06:20:28Z","timestamp":1317795628000},"source":"Crossref","is-referenced-by-count":77,"title":["Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in spain: the MERENA observational cohort study"],"prefix":"10.1186","volume":"12","author":[{"given":"Alberto","family":"Mart\u00ednez-Castelao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L","family":"G\u00f3rriz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Portol\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"De Alvaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Lu\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F","family":"Navarro-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"De la Cruz-Troca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Batlle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"17","key":"241_CR1","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of Chronic Kidney Disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001\/jama.298.17.2038.","journal-title":"JAMA"},{"issue":"6","key":"241_CR2","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2215\/CJN.02330508","volume":"3","author":"RA Rettig","year":"2008","unstructured":"Rettig RA, Norris K, Nissenson AR: Chronic Kidney Disease in the United States: A Public Policy Imperative. Clin J Am Soc Nephrol. 2008, 3 (6): 1902-1910. 10.2215\/CJN.02330508.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"241_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.02830806","volume":"2","author":"P Ruggenenti","year":"2007","unstructured":"Ruggenenti P, Remuzzi G: Kidney Failure Stabilizes after a Two-Decade Increase: Impact on Global (Renal and Cardiovascular) Health. Clin J Am Soc Nephrol. 2007, 2 (1): 146-150.","journal-title":"Clin J Am Soc Nephrol"},{"key":"241_CR4","doi-asserted-by":"crossref","unstructured":"Batlle D, Ramadugu P, Soler MJ: Progress in retarding the progression of advanced chronic kidney disease: Grounds for optimism. Kidney Int. 70 (S104): S40-S44.","DOI":"10.1038\/sj.ki.5001976"},{"issue":"1","key":"241_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.ackd.2006.07.009","volume":"14","author":"A Serrano","year":"2007","unstructured":"Serrano A, Huang J, Ghossein C, Nishi L, Gangavathi A, Madhan V, Ramadugu P, Ahya SN, Paparello J, Khosla N, Schlueter W, Batlle D: Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5. Adv Chronic Kidney Dis. 2007, 14 (1): 105-112. 10.1053\/j.ackd.2006.07.009.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"13","key":"241_CR6","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351 (13): 1296-1305. 10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"issue":"6","key":"241_CR7","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004, 164 (6): 659-663. 10.1001\/archinte.164.6.659.","journal-title":"Arch Intern Med"},{"issue":"1","key":"241_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1056\/NEJMcp0906797","volume":"362","author":"H Abboud","year":"2010","unstructured":"Abboud H, Henrich WL: Clinical practice. Stage IV chronic kidney disease. N Engl J Med. 2010, 362 (1): 56-65. 10.1056\/NEJMcp0906797.","journal-title":"N Engl J Med"},{"issue":"1","key":"241_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2369-10-26","volume":"10","author":"D Weiner","year":"2009","unstructured":"Weiner D, Krassilnikova M, Tighiouart H, Salem D, Levey A, Sarnak M: CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort study. BMC Nephrology. 2009, 10 (1): 26-10.1186\/1471-2369-10-26.","journal-title":"BMC Nephrology"},{"issue":"4","key":"241_CR10","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/j.1523-1755.2005.00553.x","volume":"68","author":"DG Warnock","year":"2005","unstructured":"Warnock DG, McClellan W, McClure LA, Newsome B, Campbell RC, Audhya P, Cushman M, Howard VJ, Howard G: Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: Baseline results. Kidney Int. 2005, 68 (4): 1427-1431. 10.1111\/j.1523-1755.2005.00553.x.","journal-title":"Kidney Int"},{"issue":"5","key":"241_CR11","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW: Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003, 42 (5): 1050-1065. 10.1161\/01.HYP.0000102971.85504.7c.","journal-title":"Hypertension"},{"key":"241_CR12","first-page":"78","volume-title":"Prevalence of chronic renal disease in Spain: Results of the EPIRCE study Nefrologia","author":"A Otero","year":"2010","unstructured":"Otero A, Gayoso P, Garcia F, de Francisco AL, on behalf of the EPIRCE Study Group: Prevalence of chronic renal disease in Spain: Results of the EPIRCE study Nefrologia. 2010, 30: 78-86."},{"issue":"3","key":"241_CR13","first-page":"300","volume":"27","author":"ALM de Francisco","year":"2007","unstructured":"de Francisco ALM, De la Cruz JJ, Cases A, de la Figuera M, Egocheaga MI, G\u00f3rriz JL, Llisterri JI, Mar\u00edn R, Mart\u00ednez Castelao A: [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study]. Nefrologia. 2007, 27 (3): 300-312.","journal-title":"Nefrologia"},{"key":"241_CR14","unstructured":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-266."},{"issue":"3","key":"241_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.ki.5000085","volume":"69","author":"L De Nicola","year":"2006","unstructured":"De Nicola L, Minutolo R, Chiodini P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G: Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006, 69 (3): 538-545. 10.1038\/sj.ki.5000085.","journal-title":"Kidney Int"},{"issue":"8","key":"241_CR16","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.2215\/CJN.00070109","volume":"4","author":"JP Lash","year":"2009","unstructured":"Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI: Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol. 2009, 4 (8): 1302-1311. 10.2215\/CJN.00070109.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"241_CR17","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1681\/ASN.2005121273","volume":"17","author":"SI Hallan","year":"2006","unstructured":"Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006, 17 (8): 2275-2284. 10.1681\/ASN.2005121273.","journal-title":"J Am Soc Nephrol"},{"key":"241_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009, 150: 604-612.","journal-title":"Ann Intern Med"},{"issue":"Suppl 2","key":"241_CR19","first-page":"1","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Aljama P, B\u00e1r\u00e1ny P, Canaud B, Carrera F, Eckardt KU, H\u00f6rl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S: Revised European Best Practice Guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004, 19 (Suppl 2): 1-47.","journal-title":"Nephrol Dial Transplant"},{"issue":"4 Suppl 2","key":"241_CR20","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1053\/j.ajkd.2007.12.017","volume":"51","author":"PA McCullough","year":"2008","unstructured":"McCullough PA, Li S, Jurkovitz CT, Stevens LA, Wang C, Collins AJ, Chen S, Norris KC, McFarlane SI, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti JA, Whaley-Connell AT: KD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008, 51 (4 Suppl 2): S38-45.","journal-title":"Am J Kidney Dis"},{"key":"241_CR21","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005, 45 (4 Suppl 3): S1-153.","DOI":"10.1053\/j.ajkd.2005.01.019"},{"issue":"10","key":"241_CR22","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1056\/NEJMoa0910975","volume":"363","author":"LJ Appel","year":"2010","unstructured":"Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010, 363 (10): 918-929. 10.1056\/NEJMoa0910975.","journal-title":"N Engl J Med"},{"issue":"4","key":"241_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000319637","volume":"32","author":"R Agarwal","year":"2010","unstructured":"Agarwal R: Debate: CON Position. People with Chronic Kidney Disease Should Have a Blood Pressure Lower than 130\/80 mm Hg. Am J Nephrol. 2010, 32 (4): 374-376. 10.1159\/000319637.","journal-title":"Am J Nephrol"},{"key":"241_CR24","doi-asserted-by":"crossref","unstructured":"IV. NKF-K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis. 2001, 37 (1 Suppl 1): S182-238.","DOI":"10.1016\/S0272-6386(01)70008-X"},{"issue":"9559","key":"241_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0140-6736(07)60165-2","volume":"369","author":"GFM Strippoli","year":"2007","unstructured":"Strippoli GFM, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC: Haemoglobin targets: we were wrong, time to move on. Lancet. 2007, 369 (9559): 346-350. 10.1016\/S0140-6736(07)60165-2.","journal-title":"Lancet"},{"issue":"1","key":"241_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1681\/ASN.2009111127","volume":"21","author":"AK Singh","year":"2010","unstructured":"Singh AK: Does TREAT give the boot to ESAs in the treatment of CKD anemia?. J Am Soc Nephrol. 2010, 21 (1): 2-6. 10.1681\/ASN.2009111127.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"241_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1634\/theoncologist.2009-S1-57","volume":"14","author":"F Locatelli","year":"2009","unstructured":"Locatelli F, Gasc\u00f3n P: Is nephrology more at ease than oncology with erythropoiesis-stimulating agents? Treatment guidelines and an update on benefits and risks. Oncologist. 2009, 14 (Suppl 1): 57-62.","journal-title":"Oncologist"},{"issue":"21","key":"241_CR28","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen C, Cooper ME, de Zeeuw D, Eckardt K, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving H, Remuzzi G, Singh AK, Solomon SD, Toto R: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009, 361 (21): 2019-2032. 10.1056\/NEJMoa0907845.","journal-title":"N Engl J Med"},{"issue":"4","key":"241_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","volume":"22","author":"L Craver","year":"2007","unstructured":"Craver L, Marco MP, Mart\u00ednez I, Rue M, Borr\u00e0s M, Mart\u00edn ML, Sarr\u00f3 F, Valdivielso JM, Fern\u00e1ndez E: Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K\/DOQI target ranges. Nephrol Dial Transplant. 2007, 22 (4): 1171-1176. 10.1093\/ndt\/gfl718.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"241_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000092033","volume":"26","author":"H Abboud","year":"2006","unstructured":"Abboud H, Coyne D, Smolenski O, Anger M, Lunde N, Qiu P, Hippensteel R, Pradhan RS, Palaparthy RV, Kavanaugh A, Melnick JZ, Williams LA, Batlle D: A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4. Am J Nephrol. 2006, 26 (1): 105-114. 10.1159\/000092033.","journal-title":"Am J Nephrol"},{"key":"241_CR31","doi-asserted-by":"crossref","unstructured":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003, 42 (4 Suppl 3): S1-201.","DOI":"10.1016\/S0272-6386(03)00905-3"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-12-53\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-12-53.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T02:44:35Z","timestamp":1560739475000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-12-53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-12-53","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]},"article-number":"53"}}